Manulife (Manufacturers Life Insurance)
AURA icon

Manulife (Manufacturers Life Insurance)’s Aura Biosciences AURA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$384K Sell
57,419
-1,820
-3% -$10.4K ﹤0.01% 2257
2025
Q4 		$325K Sell
59,239
-419
-0.7% -$2.49K ﹤0.01% 2336
2025
Q3 		$369K Sell
59,658
-913
-2% -$5.97K ﹤0.01% 2317
2025
Q2 		$379K Sell
60,571
-1,818
-3% -$10.6K ﹤0.01% 2283
2025
Q1 		$366K Sell
62,389
-687
-1% -$5.2K ﹤0.01% 2278
2024
Q4 		$518K Sell
63,076
-777
-1% -$7.31K ﹤0.01% 2217
2024
Q3 		$569K Sell
63,853
-599
-0.9% -$5.14K ﹤0.01% 2216
2024
Q2 		$487K Buy
64,452
+8,194
+15% +$60K ﹤0.01% 2228
2024
Q1 		$442K Buy
56,258
+320
+0.6% +$2.65K ﹤0.01% 2254
2023
Q4 		$496K Hold
55,938
– – ﹤0.01% 2174
2023
Q3 		$502K Hold
55,938
– – ﹤0.01% 2140
2023
Q2 		$691K Buy
55,938
+3,947
+8% +$42.2K ﹤0.01% 1851
2023
Q1 		$482K Buy
51,991
+9,406
+22% +$97.7K ﹤0.01% 2028
2022
Q4 		$442K Buy
+42,585
New +$542K ﹤0.01% 2069

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AURA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Aura Biosciences (AURA) stake by 3.1% in Q1 2026, selling an estimated $10.4K and leaving 57,419 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

Manulife (Manufacturers Life Insurance) first reported a position in AURA in Q4 2022 and has held it in 14 quarters since. The position peaked at $691K in Q2 2023. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 57,419 shares of Aura Biosciences worth $384K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,820 Aura Biosciences shares in Q1 2026, an estimated $10.4K.
  • Aura Biosciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2257 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Aura Biosciences in Q4 2022 and has held it in 14 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Aura Biosciences position peaked at $691K in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.